Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for CNS applications per local Directions for Use (DFU)
• Signed a valid, IRB/EC/REB-approved informed consent form
Locations
Other Locations
Germany
Uniklinik Köln
RECRUITING
Cologne
Universitaetsklinikum Dusseldorf
RECRUITING
Düsseldorf
Universitaetsklinikum Wuerzburg
RECRUITING
Würzburg
United Kingdom
St. Georges Hospital
RECRUITING
London
Contact Information
Primary
Stephanie Delvaux
BSNClinicalTrials@bsci.com
855-213-9890
Backup
Diane Keesey
BSNClinicalTrials@bsci.com
855-213-9890
Time Frame
Start Date: 2024-01-29
Estimated Completion Date: 2035-12
Participants
Target number of participants: 200
Treatments
Boston Scientific Radiofrequency Ablation Systems
Subjects treated with Boston Scientific commercially approved radiofrequency (RF) ablation systems in the central nervous system (CNS).
Related Therapeutic Areas
Sponsors
Leads: Boston Scientific Corporation